Trending...
- California: Governor Newsom announces appointments 9.10.25 - 424
- John Thomas calls for unity and prayer after tragic loss - 385
- Ayurveda, Ayurvedic medical Science and Ayurvedic Therapies, Dr.Abhay Kumar Pati - 379
SANTA CLARA, Calif., July 22, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Global RNA Therapeutics: Technology Growth Opportunities, reveals that ribonucleic acid (RNA) therapeutics is poised to gain momentum in the next few years and can potentially be applied to a wide variety of disease interventions. Additionally, the growth opportunities exposed by the initial commercialization of mRNA vaccines, antisense oligonucleotides (ASOs) and short interfering RNA (siRNA)-based therapeutics are further attracting pharmaceutical and biotechnology companies to invest in this space and expedite research and development (R&D).
For further information on this analysis, please visit: http://frost.ly/62g
"Advances in RNA stability, manufacturing, chemical modification, and targeted delivery systems have led to the commercial translation of RNA therapeutics," said Ruplekha Choudhurie, TechVision Industry Analyst at Frost & Sullivan. "RNAs are relatively easy to manufacture, cost-effective, and can act on undruggable targets. As a result, academic labs and small biotech companies are accelerating RNA therapeutics research, alongside Tier 1 biopharmaceutical companies."
More on The Californer
- Who Will Win the 2025 WNBA Finals? OddsTrader Shares Live Betting Odds and Projections
- Silva Construction Weighs In on the Most Popular Home Design Trends for 2026
- Geeks5g Creative Marketing: The Powerhouse Behind Business Growth
- Wise Business Plans Now Serves Entrepreneurs in Los Angeles with Tailored Business Plan Writing
- Proposition 1 continues delivering support for vulnerable homeless populations in California
Choudhurie added: "RNAs have certain advantages over deoxyribonucleic acid (DNA) and small molecule drugs, such as eliminating the risk of genomic integration, being relatively cost-effective, and having rapid development and production. Hence, RNA therapeutics investment has a better chance of commercial success and enables better returns in less time for market participants. Specifically, for the development of vaccines for COVID-19 and other emerging infectious disease outbreaks, mRNA vaccines have an advantage over other types of vaccines as they can be rapidly developed and amenable to modifications to target evolving viral variants."
The advantages of RNA therapeutics over conventional small molecule drugs and other biological drugs present immense growth opportunities for market players, including:
- Formulation and delivery of RNA therapeutics: Lipid-nanoparticles were used for delivery formulation in the previously approved RNA therapeutics, and similar (RNA-LNPs) formulations have been considered standard. Rapid formulation and delivery advances will improve the future of RNA delivery and help overcome the intrinsic stability issues of RNA.
- Stability of mRNA vaccines and RNA therapeutics at ambient temperature: Novel formulations that improve mRNA stability at ambient temperatures would facilitate the worldwide application of mRNA vaccines more rapidly and at a much lower cost. This will benefit mRNA vaccines and the entire RNA therapeutics field in general.
- mRNA vaccines and active participation of big pharmaceutical companies: Currently, RNA therapeutics is one of the fastest and most promising approaches in biological therapeutics. Due to this, many stakeholders are investing heavily in mRNA vaccines.
Global RNA Therapeutics: Technology Growth Opportunities is the latest addition to Frost & Sullivan's TechVision research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.
More on The Californer
- Agemin Unveils Breakthrough AI Model for Biometric Age Estimation, Setting New Standards in Online Child Safety
- Turnout Secures $21M in Seed Funding to Fuel Mission to Simplify Government Bureaucracy
- Teamsters Local 2010, UC Labor Unions File Historic Lawsuit Against Trump Administration
- Strategic Partnerships with Defiant Space Corp and Emtel Energy USA Powerfully Enhance Solar Tech Leader with NASA Agreements: Ascent Solar $ASTI
- 120% Revenue Surge with Four Straight Profitable Quarters Signal a Breakout in the Multi-Billion Dollar Homebuilding Market: Innovative Designs $IVDN
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
Global RNA Therapeutics: Technology Growth Opportunities
DA00
Contact:
Mariana Fernandez
Corporate Communications
E: [email protected]
http://ww2.frost.com
SOURCE Frost & Sullivan
Related Links
www.frost.com
Filed Under: Business
0 Comments
Latest on The Californer
- Sharks and Seaside Resilience in Great White Summer on Documentary Showcase
- Finding LVN Jobs in Los Angeles: A Premier Local Agency in LA County Offers Personalized Help
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Affinity Nightlife's Post Awards After Party Celebrated with the Industry's Biggest Stars
- Local consultant shows small businesses how to turn red tape into real money
- Stringify AI Launches Complaint Classifier to Automate Enterprise Support Triage
- Hazel-E Hosts Pop-Up Gifting Suite on Melrose
- iPOP Administration & Talent Fund Clean Water Project in Africa, Through the Thirst Project
- California: Governor Newsom announces appointments 9.16.25
- Hollywood Veterans and Rising Stars Join Forces on "HOA" A Vertical Sitcom Designed for Social Media
- LVN Jobs in LA Establishes Local Presence Offers In-Person Staffing Solutions for LA LVN Job Seekers
- Meet a Scientologist Tunes Up with Auto Expert Jimmy Alauria
- City of Long Beach Launches Second Cohort of Urban Planning and Design Internship Program
- California: Governor Newsom launches new statewide service effort to support the well-being of young men
- California: Governor, First Partner statement on the passing of Robert Redford
- 'The Lonely Diners Club' Goes Into Pre-Production
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- Changzhou Huifeng Vehicle Parts Factory Continues Participation 2025 AAPEX Show at Las Vegas
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
- Attn: Business: Looking for ways to Increase your Sales and Profit? Start using this Marketing Math